Answers are grounded in this paper and cite their sources.
This case report describes the off-label use of a ventricular septal defect occluder for treating a large mitral paravalvular leak in the early postoperative period.
An 81-year-old woman was admitted for heart failure in the context of degenerative valvular disease; she had previously undergone mitral and aortic valve replacement with bioprostheses and tricuspid annuloplasty.
No takes yet. Share an insight, caveat, or question.
Unzué et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: